Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04710563 · ClinicalTrials.gov registry record
SCOPE-CLI: Shifting Care and Outcomes for Patients With Endangered Limbs
A clinical trial of Peripheral Arterial Disease, sponsored by Yale University.
- Active
- Registry status
- 458
- Enrollment target
- 1
- Study location
NCT04710563 is a study of Peripheral Arterial Disease that is active but no longer recruiting, run by Yale University. The registered enrollment target is 458 participants, below the 4,200-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04710563, a study of Peripheral Arterial Disease, is active but no longer recruiting, sponsored by Yale University.
- ACTIVE NOT RECRUITING
- Registry status
- 458 participants
- Enrollment target
- 1
- Study location
Study Summary
A research project capturing experiences of patients with critical limb threatening ischemia, with the ultimate goal of setting new standards for diagnosing, describing detailed patient-centered outcomes, and evaluating the variability in therapeutic approaches and their association with outcomes.
Conditions Studied
Study Locations (1)
Connecticut
- Yale New Haven Health - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 458 participants |
| Start Date | 2021-08-11 |
| Est. Completion | 2028-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04710563
The ClinicalTrials.gov registry entry for NCT04710563 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 458 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,200-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (89% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Peripheral Arterial Disease appearing as the primary indexed condition, and to 0 interventions.
NCT04710563 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT04710563 about?
NCT04710563 is a clinical study titled "SCOPE-CLI: Shifting Care and Outcomes for Patients With Endangered Limbs". A research project capturing experiences of patients with critical limb threatening ischemia, with the ultimate goal of setting new standards for diagnosing, describing detailed patient-centered outcomes, and evaluating the variability in therapeutic approaches and their association with outcomes.
What is the current status of trial NCT04710563?
This trial is currently active not recruiting. The enrollment target is 458 participants. The study started on 2021-08-11. Estimated completion is 2028-09.
What conditions does trial NCT04710563 study?
This clinical trial studies the following conditions: Peripheral Arterial Disease.
Who is sponsoring clinical trial NCT04710563?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04710563 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Arterial Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
SELUTION4BTK Trial
RECRUITING · NA
-
MitoQ Treatment of Claudication: Myofiber and Micro-vessel Pathology
RECRUITING · NA
-
A Real-World Registry of Chronic Wounds and Ulcers
RECRUITING
-
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
RECRUITING · Phase 3
-
Ramipril Treatment of Claudication: Oxidative Damage and Muscle Fibrosis
RECRUITING · Phase 4
-
Ultrasound Perfusion Estimation for Assessment of Peripheral Arterial Disease
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.